Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re:millions added to the pot, APCC 2006 Q2 Net Revenue

Net revenue for the second quarter 2006 was $560.0 million, up 17 percent from $480.6 million in the second quarter 2005.

Be well

5
Oct 04, 2007 06:23AM
2
Oct 04, 2007 07:56AM

Oct 04, 2007 08:07AM
1
Oct 04, 2007 08:09AM
2
Oct 04, 2007 08:26AM

Oct 04, 2007 08:37AM
2
Oct 04, 2007 08:48AM
Share
New Message
Please login to post a reply